Humanigen Inc (HGENQ)

[cowtown jay]

"Gracell Biotechnologies Announces FDA Clearance of IND Application"

Look at the FDA Approvals section for ticker GRCL.

https://newsfilter.io/


"This progress marks the second U.S. IND clearance for GC012F, a notable milestone. As a next-generation CAR-T therapy, GC012F combines the innovative CD19/BCMA dual-targeting approach and our breakthrough FasTCAR next-day manufacturing technology, both of which could potentially provide meaningful benefits to SLE patients. Additionally, what sets GC012F apart is its consistently favorable safety profile demonstrated by the absence of neurotoxicity in 60 patients treated across three IIT studies. We look forward to developing GC012F as a transformative therapy for SLE patients, who are in urgent need of highly effective and safe treatment options."

Does lenz provide the enhanced safety and efficacy of this CAR-T therapy?